TY  - GEN
AU  - Schneider,Constanze
AU  - Oellerich,Thomas
AU  - Baldauf,Hanna-Mari
AU  - Schwarz,Sarah-Marie
AU  - Thomas,Dominique
AU  - Flick,Robert
AU  - Bohnenberger,Hanibal
AU  - Kaderali,Lars
AU  - Stegmann,Lena
AU  - Cremer,Anjali
AU  - Martin,Margarethe
AU  - Lohmeyer,Julian
AU  - Michaelis,Martin
AU  - Hornung,Veit
AU  - Schliemann,Christoph
AU  - Berdel,Wolfgang E
AU  - Hartmann,Wolfgang
AU  - Wardelmann,Eva
AU  - Comoglio,Federico
AU  - Hansmann,Martin-Leo
AU  - Yakunin,Alexander F
AU  - Geisslinger,Gerd
AU  - Ströbel,Philipp
AU  - Ferreirós,Nerea
AU  - Serve,Hubert
AU  - Keppler,Oliver T
AU  - Cinatl,Jindrich
TI  - SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
SN  - 1546-170X
PY  - 2017///0814
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Animals
KW  - Antimetabolites, Antineoplastic
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Apoptosis
KW  - drug effects
KW  - Cell Line, Tumor
KW  - Cytarabine
KW  - administration & dosage
KW  - Daunorubicin
KW  - Disease Models, Animal
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - Immunoblotting
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Monomeric GTP-Binding Proteins
KW  - metabolism
KW  - Prognosis
KW  - Retrospective Studies
KW  - SAM Domain and HD Domain-Containing Protein 1
KW  - Young Adult
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/nm.4255
ER  -